ION receives continued listing standard notice from the NYSE
Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…
Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…
Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
Synopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…
Summary : OceanFirst Financial Corp. (NASDAQ:”OCFC”), (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today, announced the Company has signed…
Summary : -As Australians gear up for the further reopening of international travel lanes in 2022, proof of COVID-19 vaccination is a…
Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in…
Synopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit…